Australia Venture Capital Market Size, Share, Report 2026–2034

Market Overview

The Australia Venture Capital Market reached a size of USD 4.5 Billion in 2025 and is projected to reach USD 10.3 Billion by 2034, growing at a CAGR of 8.74% during the forecast period of 2026–2034. The market is driven toward growth by strong and maturing startup ecosystems, increasing government incentives, significant innovation in technology sectors, and growing interest from both domestic and international investors seeking high-growth opportunities in fintech, healthtech, AI, clean energy, and deep tech. Australian startups raised USD 5.1 Billion across 390 deals in 2025 — the third biggest funding year on record — with the final quarter of 2025 delivering the strongest funding allocation since 2021, signaling a decisive return of confidence to Australian venture capital. AI has emerged as the defining investment theme, with more than USD 1 Billion allocated to AI-native startups in 2025, and companies building with AI in their stack attracting 61% of total funding — reflecting a fundamental shift from AI as a novelty to AI as a core commercial differentiator rewarded by sophisticated investors. Australia’s startup ecosystem has placed third globally in liquidity after the United States and China, generating 1.5 unicorns for every billion dollars invested — surpassing both China and the US — driven by the capital efficiency and international market orientation of Australian startups. The ecosystem has produced 32 unicorns including Canva (valued at USD 40 Billion), Atlassian, and Afterpay. International investors were involved in 57% of deals in 2024, underscoring Australia’s growing reputation as a globally connected innovation hub. New South Wales historically dominated by market share, but Victoria took the venture capital crown from NSW in 2025, with capital concentrated in fintech, biotech and medtech, climate tech, and healthtech.

How AI is Reshaping the Future of the Australia Venture Capital Market:

• AI has structurally transformed the Australian VC funding landscape from a sector-specific investment theme into a cross-category enabler — with 75% of startups that raised capital in 2025 having an AI product on the shelf, suggesting AI is increasingly embedded across categories rather than operating as a distinct vertical, and that including an AI angle became necessary to attract funding in 2025.
• Melbourne-based AI healthtech Heidi Health — which automates clinical documentation and reduces administrative burden for healthcare providers — raised USD 98 Million in a Series B round in October 2025, just seven months after topping up its Series A, pushing its valuation to USD 704 Million — exemplifying the premium valuations and accelerated funding velocity that AI-native healthcare startups are attracting from Australian and international VC investors.
• Airwallex — the Melbourne-founded global payments and treasury infrastructure platform — raised a combined USD 964 Million across a USD 466 Million Series F in May 2025 and a USD 498 Million Series G in late 2025, lifting its valuation to USD 12 Billion and delivering the single largest combined fundraising effort by an Australian startup in 2025, with its 2025 strategy pivoting to embed AI agents directly into financial operations, betting that autonomous finance will underpin its next growth phase ahead of a likely IPO.
• Cut Through Venture founder Chris Gillings observed that AI has acted as the accelerant for the Australian VC market — not because “AI” sells, but because it compresses time, allowing teams to ship, iterate, and prove value faster, pulling more companies into a fundable position earlier — while investor filters have matured, moving past novelty to reward defensibility, distribution, data advantage, and clear paths to monetization.
• Deep tech AI applications in Australia — spanning Harrison.ai in medical imaging, Morse Micro in Wi-Fi chip design, and Neara in AI-powered predictive modeling for critical infrastructure — are attracting significant VC capital precisely because AI is enabling small Australian teams to build globally competitive products in capital-intensive technology domains, compressing the time and investment historically required to reach product-market fit and scalable commercialization.

Request Industry-Focused Sample with Insights & Forecasts

https://www.imarcgroup.com/australia-venture-capital-market/requestsample

Market Trends and Insights

• AI as the Dominant Investment Theme: The top sector for VC funding across Australia in 2025 was AI, with more than USD 1 Billion allocated to AI-native startups and 61% of total funding going to startups building with AI in their stack — establishing AI not merely as a vertical but as the evaluative lens through which investors across fintech, healthtech, climate tech, and SaaS assess competitive moat and growth trajectory in every deal.
• Median Deal Sizes Surging Across All Stages: Median deal sizes rose across every stage in 2025 — with pre-seed median rounds increasing to USD 925,000 from USD 675,000 in 2024, seed medians lifting to USD 3.2 Million, Series A median climbing to USD 15 Million from USD 6 Million, and Series B+ medians rising to USD 40 Million from USD 17 Million — signaling a marked improvement in investor conviction and startup quality filtering through to better pricing across the funding continuum.
• Victoria Overtaking NSW as the Largest VC Hub: Victoria led all states in total VC capital in 2025, with capital concentrated in fintech (USD 759 Million) and biotech and medtech (USD 526 Million), followed by climate tech and healthtech — driven largely by Airwallex’s blockbuster dual raises, though the underlying strength across multiple sectors reflects Melbourne’s deepening advantages in life sciences, fintech infrastructure, and climate technology investment ecosystems.
• Late-Stage Deal Activity Recovering: Later stage deals saw increased activity for rounds between USD 20 Million and USD 50 Million, rising from 27 in 2024 to 42 in 2025 — addressing the historically persistent late-stage funding gap that had compelled Australian high-growth companies to seek overseas investors prematurely, with improved domestic late-stage availability beginning to retain more intellectual property and operational headquarters within Australia through scaling phases.
• Founder Confidence at Multi-Year High: 86% of 1,000 local founders surveyed reported confidence they will raise their next round — up from 76% in 2024 — with most planning to raise in the next 12 months, representing the highest founder sentiment reading since the 2021 boom and reflecting the combined effect of AI-driven deal activity, recovering valuations, and improving international investor participation in the Australian ecosystem.

Software remains the largest sector by VC investment volume, encompassing enterprise SaaS, AI-native platforms, cloud infrastructure, and developer tools — with Australia’s enterprise software sector producing globally competitive companies including Atlassian, Canva, and SafetyCulture that validate the market’s capacity to build high-value software businesses serving international markets. Pharma and biotech is the second-largest sector, anchored by strong university spin-out infrastructure — with Australia leading globally in university spinout investments, with over half of its 43 universities operating an investment fund — and dedicated life sciences VC funds including Brandon Capital’s AUD 270 Million Fund VI and WEHI’s AUD 66 Million 66ten fund. Energy is the fastest-growing sector, driven by climate tech and clean energy investment encompassing green hydrogen, long-duration energy storage, solar technology, and cleantech infrastructure — with RayGen’s USD 127 Million Series D in 2025 exemplifying the capital intensity and strategic importance of this segment.

By fund size, the USD 100 Million to USD 250 Million tier is the most active for established Australian VC firms deploying into growth-stage companies, while above USD 250 Million funds are growing in number and scale as Australian superannuation funds — with AustralianSuper managing AUD 341 Billion and UniSuper managing AUD 139 Billion — progressively increase allocations to domestic venture capital as an asset class. By funding type, follow-on venture funding holds the dominant share, reflecting the high proportion of existing portfolio companies receiving additional rounds as their metrics improve — with 86% of founders expecting to raise again within 12 months sustaining consistent follow-on deal flow. First-time venture funding is growing as AI compression of product development timelines brings more startups into fundable condition earlier. Regionally, New South Wales historically leads by total VC volume — anchored by Sydney’s concentration of fintech, deep tech, and enterprise software startups and proximity to Asian markets — while Victoria surged ahead in 2025 on the strength of Airwallex and its life sciences cluster. Queensland is the fastest-growing regional market with a 120% funding increase driven by agtech, mining technology, and logistics startups.

Market Growth Drivers

Government Support and Policies

The Australian government has been instrumental in building and sustaining the venture capital market through targeted co-investment programs, R&D tax incentives, and sector-specific innovation funds that materially reduce the financial risks associated with early-stage venture investment. The Innovation Investment Fund (IIF) — which stimulates innovation by co-investing with private venture capital — the Renewable Energy Venture Capital (REVC) Programme, the Biomedical Translation Fund (BTF) bridging biomedical research and commercialization, and the Queensland Venture Capital Development Fund (QVCD) promoting venture growth in Queensland’s tech sectors have collectively lowered entry barriers for investors and fostered a culture of innovation across sectors. Breakthrough Victoria’s AUD 2 Billion fund is driving commercialization from university research — with Australia leading globally in university spinout investments, with more than half of its 43 universities operating a dedicated investment fund, surpassing both the United States at 33% and Europe at 40%. The R&D Tax Incentive Program — providing 43.5% tax offset for eligible expenditure for companies with turnover under AUD 20 Million — directly reduces the effective cost of innovation investment for startups and their VC backers. In 2025, medtech startup Synchron secured USD 305 Million in Series D funding, with USD 54 Million co-invested by Australia’s National Reconstruction Fund, exemplifying the government’s direct role as a co-investor alongside private VC in strategic deep technology sectors.

Increasing Focus on Tech and Innovation Sectors

Australia’s VC market has experienced strong structural growth driven by the rising dominance of technology and innovation-focused sectors — with fintech, biotech, AI, and clean energy attracting disproportionate investor attention due to their high growth potential, scalable business models, and alignment with global megatrends. Fintech raised USD 947 Million in 2024, rising sharply from 2023, with Airwallex’s dual USD 964 Million combined raise in 2025 cementing the sector’s position as Australia’s single largest VC investment category by capital deployed. AI startups captured more than USD 1 Billion in 2025 funding alone. In September 2024, SafetyCulture — the Australian workplace operations platform — secured a USD 165 Million funding round led by Airtree Ventures, representing the largest software-related funding round of 2024 and the third-largest overall, demonstrating the depth of institutional investor appetite for Australian enterprise software businesses with proven international traction. The country’s strong research universities, CSIRO’s Data61 commercialization program, and thriving tech precincts including Sydney’s Tech Central and the Melbourne Biomedical Precinct provide a continuously replenishing pipeline of investment-grade innovation across software, life sciences, advanced manufacturing, and clean energy.

Growing Entrepreneurial Ecosystem

Australia’s entrepreneurial ecosystem has expanded rapidly and continues to mature — creating the dense network of founders, investors, accelerators, incubators, corporate venture arms, and research commercialization programs that provides the structural foundation for sustained VC market growth. The ecosystem has produced 32 unicorns including Canva, Atlassian, and Afterpay, establishing credible proof of Australian startups’ ability to build globally significant companies despite a domestic market of just 26 million people. Corporate venture capital activity is expanding across financial services, energy, telecommunications, and healthcare — with CVC-backed startups gaining the dual benefit of growth capital and strategic market access through corporate partner channels. The expanding superannuation system — with AustralianSuper managing AUD 341 Billion — is progressively increasing domestic LP allocation to venture capital, providing a growing and patient source of long-duration capital that supports the fund formation and follow-on investment capacity of the Australian VC ecosystem. 86% of Australian founders surveyed expressed confidence in their ability to raise their next round, reflecting an ecosystem that has absorbed the 2022–23 valuation correction, recalibrated growth expectations, and emerged with stronger fundamentals, better investor-founder alignment, and a clear AI-driven growth narrative that is attracting both domestic and international capital at an accelerating rate.

Market Segmentation

Sector Insights:

• Software
• Pharma and Biotech
• Media and Entertainment
• Medical Devices and Equipment
• Medical Services and Systems
• IT Hardware
• IT Services and Telecommunication
• Consumer Goods and Recreation
• Energy
• Others

Fund Size Insights:

• Under $50 M
• $50 M to $100 M
• $100 M to $250 M
• Above $250 M

Funding Type Insights:

• First-Time Venture Funding
• Follow-on Venture Funding

Regional Insights:

• Australia Capital Territory & New South Wales
• Victoria & Tasmania
• Queensland
• Northern Territory & Southern Australia
• Western Australia

Recent News and Developments

• Late 2025: Airwallex — the Melbourne-founded global payments and treasury infrastructure platform — raised a combined USD 964 Million across a USD 466 Million Series F in May 2025 and a USD 498 Million Series G in late 2025, lifting its valuation to USD 12 Billion and delivering the single largest combined fundraising effort by an Australian startup in 2025, with its strategy pivoting to embed AI agents directly into financial operations ahead of a likely IPO.
• November 2025: Medtech startup Synchron — developing brain-computer interface technology enabling paralysed patients to control devices — secured USD 305 Million in Series D funding, with USD 54 Million co-invested by Australia’s National Reconstruction Fund, validating the government’s direct venture co-investment role in strategic deep technology sectors and positioning Synchron as a globally leading BCI company.
• October 2025: Melbourne-based AI healthtech Heidi Health raised USD 98 Million in a Series B round — just seven months after topping up its Series A — pushing its valuation to USD 704 Million and reflecting strong investor appetite for AI tools that address clinical administrative burden at scale across Australian and international healthcare systems.
• July 2025: Queensland-based RayGen completed its USD 127 Million Series D for its next-generation solar and long-duration thermal storage technology — with its Carwarp facility capable of delivering up to 17 hours of continuous grid power — representing one of Australia’s largest clean energy VC raises and reflecting growing investor conviction in long-duration energy storage as a critical enabler of Australia’s renewable energy transition.
• July 2024: Sydney-based EVP announced raising USD 20 Million for its fifth fund — with plans to grow to USD 500 Million over a decade — as an evergreen fund targeting growth-stage B2B software companies in Australia and New Zealand, targeting a 25% gross internal rate of return, reflecting the maturation of Australia’s venture fund manager ecosystem toward permanent capital vehicles capable of supporting longer-duration company building.
• June 2024: Brandon Capital launched Brandon Capital Fund VI with an initial close of AUD 270 Million — expanding its remit from Australia and New Zealand into the United Kingdom, Europe, and the United States — cementing Australasia’s leading life sciences VC firm’s position as a globally connected platform for biomedical translation investment and reinforcing the life sciences sector’s role as a pillar of Australian venture capital alongside software and fintech.

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Ask analyst for your customized sample:

https://www.imarcgroup.com/request?type=report&id=24803&flag=F

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC’s offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201-971-6302